{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:59:32Z","timestamp":1793325572851,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10569-1","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:55:28Z","timestamp":1747126528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Liquid biopsy in diagnosis and monitoring of treatment efficacy in patients with small cell lung cancer"],"prefix":"10.1007","volume":"52","author":[{"given":"Natalia","family":"Galant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Pi\u0119t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Milanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"12","key":"10569_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrc.2017.87","volume":"17","author":"AF Gazdar","year":"2017","unstructured":"Gazdar AF, Bunn PA, Minna JD (2017) Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer 17(12):725\u2013737. https:\/\/doi.org\/10.1038\/nrc.2017.87","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10569_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers LA, Rudin CM (2015) Small cell lung cancer: where do we go from here? Cancer 121(5):664\u2013672. https:\/\/doi.org\/10.1002\/cncr.29098","journal-title":"Cancer"},{"issue":"6","key":"10569_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3322\/caac.21785","volume":"73","author":"Z Megyesfalvi","year":"2023","unstructured":"Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, Dome B (2023) Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions. Cancer J Clin 73(6):620\u2013652. https:\/\/doi.org\/10.3322\/caac.21785","journal-title":"Cancer J Clin"},{"issue":"8005","key":"10569_CR4","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","volume":"627","author":"J George","year":"2024","unstructured":"George J, Maas L, Abedpour N, Cartolano M, Kaiser L, Fischer RN, Thomas RK (2024) Evolutionary trajectories of small cell lung cancer under therapy. Nature 627(8005):880\u2013889. https:\/\/doi.org\/10.1038\/s41586-024-07177-7","journal-title":"Nature"},{"issue":"3","key":"10569_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.lungcan.2011.08.004","volume":"75","author":"SP Riaz","year":"2012","unstructured":"Riaz SP, L\u00fcchtenborg M, Coupland VH, Spicer J, Peake MD, M\u00f8ller H (2012) Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer 75(3):280\u2013284. https:\/\/doi.org\/10.1016\/j.lungcan.2011.08.004","journal-title":"Lung Cancer"},{"issue":"2","key":"10569_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1001\/jamaoncol.2020.6362","volume":"7","author":"DA Siegel","year":"2021","unstructured":"Siegel DA, Fedewa SA, Henley SJ, Pollack LA, Jemal A (2021) Proportion of never smokers among men and women with lung Cancer in 7 US States. JAMA Oncol 7(2):302\u2013304. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6362","journal-title":"JAMA Oncol"},{"key":"10569_CR7","doi-asserted-by":"publisher","unstructured":"Lissa, D., Takahashi, N., Desai, P., Manukyan, I., Schultz, C. W., Rajapakse, V.,\u2026 Thomas, A. (2022). Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. Nature Communications, 13(1), 2023. https:\/\/doi.org\/10.1038\/s41467-022-29517-9","DOI":"10.1038\/s41467-022-29517-9"},{"key":"10569_CR8","doi-asserted-by":"publisher","first-page":"1197044","DOI":"10.3389\/fimmu.2023.1197044","volume":"14","author":"T Zhang","year":"2023","unstructured":"Zhang T, Li W, Diwu D, Chen L, Chen X, Wang H (2023) Efficacy and safety of first-line immunotherapy plus chemotherapy in treating patients with extensive-stage small cell lung cancer: a bayesian network meta-analysis. Front Immunol 14:1197044. https:\/\/doi.org\/10.3389\/fimmu.2023.1197044","journal-title":"Front Immunol"},{"issue":"16","key":"10569_CR9","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.3390\/cancers15164016","volume":"15","author":"SR Patel","year":"2023","unstructured":"Patel SR, Das M (2023) Small cell lung cancer: emerging targets and strategies for precision therapy. Cancers 15(16):4016. https:\/\/doi.org\/10.3390\/cancers15164016","journal-title":"Cancers"},{"issue":"1","key":"10569_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J (2021) Small-cell lung cancer. Nat Reviews Disease Primers 7(1):3. https:\/\/doi.org\/10.1038\/s41572-020-00235-0","journal-title":"Nat Reviews Disease Primers"},{"key":"10569_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.semcancer.2022.04.001","volume":"86","author":"WZ Wang","year":"2022","unstructured":"Wang WZ, Shulman A, Amann JM, Carbone DP, Tsichlis PN (2022) Small cell lung cancer: subtypes and therapeutic implications. Sem Cancer Biol 86:543\u2013554. https:\/\/doi.org\/10.1016\/j.semcancer.2022.04.001","journal-title":"Sem Cancer Biol"},{"issue":"8","key":"10569_CR12","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.3390\/ijms25084208","volume":"25","author":"A Grenda","year":"2024","unstructured":"Grenda A, Krawczyk P, Obara A, Gajek \u0141, \u0141om\u017ca-\u0141aba A, Milanowski J (2024) Transitioning to a personalized approach in molecularly subtyped Small-Cell lung Cancer (SCLC). Int J Mol Sci 25(8):4208. https:\/\/doi.org\/10.3390\/ijms25084208","journal-title":"Int J Mol Sci"},{"key":"10569_CR13","doi-asserted-by":"publisher","unstructured":"Almodovar, K., Iams, W. T., Meador, C. B., Zhao, Z., York, S., Horn, L.,\u2026 Lovly,C. M. (2018). Longitudinal cell-free DNA analysis in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 13(1), 112\u2013123. https:\/\/doi.org\/10.1016\/j.jtho.2017.09.1951","DOI":"10.1016\/j.jtho.2017.09.1951"},{"key":"10569_CR14","doi-asserted-by":"publisher","unstructured":"Mohan, S., Foy, V., Ayub, M., Leong, H. S., Schofield, P., Sahoo, S.,\u2026 Brady, G.(2020). Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC. Journal of Thoracic Oncology, 15(2), 216\u2013230. https:\/\/doi.org\/10.1016\/j.jtho.2019.10.007","DOI":"10.1016\/j.jtho.2019.10.007"},{"key":"10569_CR15","doi-asserted-by":"publisher","unstructured":"Lebofsky, R., Decraene, C., Bernard, V., Kamal, M., Blin, A., Leroy, Q.,\u2026 Pierga,J.-Y. (2015). Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Molecular Oncology, 9(4), 783\u2013790. https:\/\/doi.org\/10.1016\/j.molonc.2014.12.003","DOI":"10.1016\/j.molonc.2014.12.003"},{"issue":"4","key":"10569_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","volume":"11","author":"C Alix-Panabi\u00e8res","year":"2021","unstructured":"Alix-Panabi\u00e8res C, Pantel K (2021) Liquid biopsy: from discovery to clinical application. Cancer Discov 11(4):858\u2013873. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1311","journal-title":"Cancer Discov"},{"issue":"1","key":"10569_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock R (2022) Liquid biopsy: current technology and clinical applications. Journal Hematology Oncology 15(1):131. https:\/\/doi.org\/10.1186\/s13045-022-01351-y","journal-title":"Journal Hematology Oncology"},{"issue":"5","key":"10569_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","volume":"6","author":"C Alix-Panabi\u00e8res","year":"2016","unstructured":"Alix-Panabi\u00e8res C, Pantel K (2016) Clinical applications of Circulating tumor cells and Circulating tumor DNA as liquid biopsy. Cancer Discov 6(5):479\u2013491. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-1483","journal-title":"Cancer Discov"},{"key":"10569_CR19","doi-asserted-by":"publisher","unstructured":"Chen, S., Jin, Y., Wang, S., Xing, S., Wu, Y., Tao, Y.,\u2026 Wang, P. (2022). Cancer type classification using plasma cell-free RNAs derived from human and microbes. eLife, 11, e75181. https:\/\/doi.org\/10.7554\/eLife.75181","DOI":"10.7554\/eLife.75181"},{"key":"10569_CR20","doi-asserted-by":"publisher","unstructured":"Best, M. G., Sol, N., Veld, S. G. J. G. I. \u2018t, Vancura, A., Muller, M., Niemeijer,A.-L. N.,\u2026 Wurdinger, T. (2017). Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets. Cancer Cell, 32(2), 238\u2013252.e9. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.004","DOI":"10.1016\/j.ccell.2017.07.004"},{"key":"10569_CR21","doi-asserted-by":"publisher","unstructured":"Pang, B., Zhu, Y., Ni, J., Thompson, J., Malouf, D., Bucci, J.,\u2026 Li, Y. (2020). Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis. Theranostics, 10(5), 2309. https:\/\/doi.org\/10.7150\/thno.39486","DOI":"10.7150\/thno.39486"},{"key":"10569_CR22","doi-asserted-by":"publisher","unstructured":"Lone, S. N., Nisar, S., Masoodi, T., Singh, M., Rizwan, A., Hashem, S.,\u2026 Macha, M.A. (2022). Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Molecular Cancer, 21(1), 79. https:\/\/doi.org\/10.1186\/s12943-022-01543-7","DOI":"10.1186\/s12943-022-01543-7"},{"key":"10569_CR23","doi-asserted-by":"publisher","unstructured":"Mao, S., Lu, Z., Zheng, S., Zhang, H., Zhang, G., Wang, F.,\u2026 He, J. (2020). Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer. Journal of Experimental & Clinical Cancer Research, 39(1), 193. https:\/\/doi.org\/10.1186\/s13046-020-01680-1","DOI":"10.1186\/s13046-020-01680-1"},{"key":"10569_CR24","unstructured":"Wei, T., Zhu, W., Fang, S., Zeng, X., Huang, J., Yang, J.,\u2026 Guo, L. (2017). miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk\/BMX. American Journal of Cancer Research, 7(3), 628\u2013646."},{"issue":"10","key":"10569_CR25","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1158\/1078-0432.CCR-16-1676","volume":"23","author":"K Shigeyasu","year":"2017","unstructured":"Shigeyasu K, Toden S, Zumwalt TJ, Okugawa Y, Goel A (2017) Emerging role of MicroRNAs as liquid biopsy biomarkers in Gastrointestinal cancers. Clin Cancer Res 23(10):2391\u20132399. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1676","journal-title":"Clin Cancer Res"},{"key":"10569_CR26","doi-asserted-by":"publisher","unstructured":"Li, M., Shan, W., Hong, B., Zou, J., Li, H., Han, D.,\u2026 Lin, W. (2020). Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer. Scientific Reports, 10(1), 12705. https:\/\/doi.org\/10.1038\/s41598-020-69615-6","DOI":"10.1038\/s41598-020-69615-6"},{"key":"10569_CR27","doi-asserted-by":"publisher","unstructured":"Bettoni, F., Masotti, C., Habr-Gama, A., Correa, B. R., Gama-Rodrigues, J., Vianna,M. R.,\u2026 Perez, R. O. (2017). Intratumoral Genetic Heterogeneity in Rectal Cancer:Are Single Biopsies representative of the entirety of the tumor? Annals of Surgery, 265(1), e4. https:\/\/doi.org\/10.1097\/SLA.0000000000001937","DOI":"10.1097\/SLA.0000000000001937"},{"key":"10569_CR28","doi-asserted-by":"publisher","unstructured":"Russano, M., Napolitano, A., Ribelli, G., Iuliani, M., Simonetti, S., Citarella, F.,\u2026 Santini, D. (2020). Liquid biopsy and tumor heterogeneity in metastatic solid tumors:the potentiality of blood samples. Journal of Experimental & Clinical Cancer Research, 39(1), 95. https:\/\/doi.org\/10.1186\/s13046-020-01601-2","DOI":"10.1186\/s13046-020-01601-2"},{"issue":"2","key":"10569_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cac2.12129","volume":"41","author":"H-M Huang","year":"2021","unstructured":"Huang H-M, Li H-X (2021) Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer. Cancer Commun 41(2):91\u2013108. https:\/\/doi.org\/10.1002\/cac2.12129","journal-title":"Cancer Commun"},{"issue":"3","key":"10569_CR30","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/ijms24032505","volume":"24","author":"GMS Casagrande","year":"2023","unstructured":"Casagrande GMS, Silva MdeO, Reis RM, Leal LF (2023) Liquid biopsy for lung cancer: Up-to-Date and perspectives for screening programs. Int J Mol Sci 24(3):2505. https:\/\/doi.org\/10.3390\/ijms24032505","journal-title":"Int J Mol Sci"},{"key":"10569_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","volume":"18","author":"Q Ye","year":"2019","unstructured":"Ye Q, Ling S, Zheng S, Xu X (2019) Liquid biopsy in hepatocellular carcinoma: Circulating tumor cells and Circulating tumor DNA. Mol Cancer 18:114. https:\/\/doi.org\/10.1186\/s12943-019-1043-x","journal-title":"Mol Cancer"},{"key":"10569_CR32","doi-asserted-by":"publisher","unstructured":"Freitas, A. J. A. de, Causin, R. L., Varuzza, M. B., Calfa, S., Filho, C. M. T. H.,Komoto, T. T.,\u2026 Marques, M. M. C. (2022). Liquid Biopsy as a Tool for the Diagnosis,Treatment, and Monitoring of Breast Cancer. International Journal of Molecular Sciences, 23(17), 9952. https:\/\/doi.org\/10.3390\/ijms23179952","DOI":"10.3390\/ijms23179952"},{"key":"10569_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-023-01745-7","volume":"22","author":"M Li","year":"2023","unstructured":"Li M, Li L, Zheng J, Li Z, Li S, Wang K, Chen X (2023) Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. Mol Cancer 22:37. https:\/\/doi.org\/10.1186\/s12943-023-01745-7","journal-title":"Mol Cancer"},{"issue":"3","key":"10569_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12032-023-01956-4","volume":"40","author":"Y Shen","year":"2023","unstructured":"Shen Y, Shi R, Zhao R, Wang H (2023) Clinical application of liquid biopsy in endometrial carcinoma. Med Oncol (Northwood Lond Engl) 40(3):92. https:\/\/doi.org\/10.1007\/s12032-023-01956-4","journal-title":"Med Oncol (Northwood Lond Engl)"},{"key":"10569_CR35","doi-asserted-by":"publisher","unstructured":"Sisodiya, S., Kasherwal, V., Khan, A., Roy, B., Goel, A., Kumar, S.,\u2026 Hussain, S.(2023). Liquid Biopsies: Emerging role and clinical applications in solid tumours.Translational Oncology, 35, 101716. https:\/\/doi.org\/10.1016\/j.tranon.2023.101716","DOI":"10.1016\/j.tranon.2023.101716"},{"key":"10569_CR36","doi-asserted-by":"publisher","unstructured":"Narayan, P., Ghosh, S., Philip, R., Barrett, J. C., McCormack, R. T., Odegaard, J.I.,\u2026 Beaver, J. A. (2020). State of the Science and Future Directions for Liquid Biopsies in Drug Development. The Oncologist, 25(9), 730. https:\/\/doi.org\/10.1634\/theoncologist.2020-0246","DOI":"10.1634\/theoncologist.2020-0246"},{"key":"10569_CR37","doi-asserted-by":"publisher","unstructured":"Ma, S., Zhou, M., Xu, Y., Gu, X., Zou, M., Abudushalamu, G.,\u2026 Wu, G. (2023). Clinical application and detection techniques of liquid biopsy in gastric cancer. Molecular Cancer, 22, 7. https:\/\/doi.org\/10.1186\/s12943-023-01715-z","DOI":"10.1186\/s12943-023-01715-z"},{"key":"10569_CR38","doi-asserted-by":"publisher","unstructured":"Goldberg, S. B., Narayan, A., Kole, A. J., Decker, R. H., Teysir, J., Carriero, N.J.,\u2026 Patel, A. A. (2018). Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA. Clinical Cancer Research, 24(8), 1872\u20131880. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1341","DOI":"10.1158\/1078-0432.CCR-17-1341"},{"key":"10569_CR39","doi-asserted-by":"publisher","unstructured":"Lennon, A. M., Buchanan, A. H., Kinde, I., Warren, A., Honushefsky, A., Cohain, A.T.,\u2026 Papadopoulos, N. (2020). Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science (New York, N.Y.), 369(6499), eabb9601. https:\/\/doi.org\/10.1126\/science.abb9601","DOI":"10.1126\/science.abb9601"},{"key":"10569_CR40","doi-asserted-by":"publisher","unstructured":"Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M.S.,\u2026 Alizadeh, A. A. (2016). Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Science translational medicine, 8(364), 364ra155. https:\/\/doi.org\/10.1126\/scitranslmed.aai8545","DOI":"10.1126\/scitranslmed.aai8545"},{"key":"10569_CR41","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Ricarte, F., Mayor, R., Mart\u00ednez-S\u00e1ez, E., Rubio-P\u00e9rez, C., Pineda, E., Cordero,E.,\u2026 Seoane, J. (2018). Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical Cancer Research, 24(12), 2812\u20132819. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3800","DOI":"10.1158\/1078-0432.CCR-17-3800"},{"issue":"9","key":"10569_CR42","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S1470-2045(18)30455-8","volume":"19","author":"F Blackhall","year":"2018","unstructured":"Blackhall F, Frese KK, Simpson K, Kilgour E, Brady G, Dive C (2018) Will liquid biopsies improve outcomes for patients with small-cell lung cancer? Lancet Oncol 19(9):e470\u2013e481. https:\/\/doi.org\/10.1016\/S1470-2045(18)30455-8","journal-title":"Lancet Oncol"},{"key":"10569_CR43","doi-asserted-by":"publisher","unstructured":"Ireland, A. S., Micinski, A. M., Kastner, D. W., Guo, B., Wait, S. J., Spainhower,K. B.,\u2026 Oliver, T. G. (2020). MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer cell, 38(1), 60\u201378.e12. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.001","DOI":"10.1016\/j.ccell.2020.05.001"},{"key":"10569_CR44","doi-asserted-by":"publisher","unstructured":"Seo, J., Kumar, M., Mason, J., Blackhall, F., Matsumoto, N., Dive, C.,\u2026 Shishido,S. N. (2023). Plasticity of circulating tumor cells in small cell lung cancer. Scientific Reports, 13(1), 11775. https:\/\/doi.org\/10.1038\/s41598-023-38881-5","DOI":"10.1038\/s41598-023-38881-5"},{"key":"10569_CR45","doi-asserted-by":"publisher","first-page":"175883592097419","DOI":"10.1177\/1758835920974192","volume":"12","author":"JA Vendrell","year":"2020","unstructured":"Vendrell JA, Quantin X, Serre I, Solassol J (2020) Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment. Therapeutic Adv Med Oncol 12:1758835920974192. https:\/\/doi.org\/10.1177\/1758835920974192","journal-title":"Therapeutic Adv Med Oncol"},{"key":"10569_CR46","doi-asserted-by":"publisher","unstructured":"Nunes, S. P., Diniz, F., Moreira-Barbosa, C., Const\u00e2ncio, V., Silva, A. V., Oliveira,J.,\u2026 Jer\u00f3nimo, C. (2019). Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies.Journal of Clinical Medicine, 8(9), 1500. https:\/\/doi.org\/10.3390\/jcm8091500","DOI":"10.3390\/jcm8091500"},{"key":"10569_CR47","doi-asserted-by":"publisher","unstructured":"Chemi, F., Pearce, S. P., Clipson, A., Hill, S. M., Conway, A.-M., Richardson, S.A.,\u2026 Dive, C. (2022). cfDNA methylome profiling for detection and subtyping of small cell lung cancers. Nature Cancer, 3(10), 1260. https:\/\/doi.org\/10.1038\/s43018-022-00415-9","DOI":"10.1038\/s43018-022-00415-9"},{"key":"10569_CR48","doi-asserted-by":"publisher","unstructured":"Baine, M. K., Hsieh, M.-S., Lai, W. V., Egger, J. V., Jungbluth, A., Daneshbod, Y.,\u2026 Rekhtman, N. (2020). Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1,POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization.Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 15(12), 1823. https:\/\/doi.org\/10.1016\/j.jtho.2020.09.009","DOI":"10.1016\/j.jtho.2020.09.009"},{"key":"10569_CR49","doi-asserted-by":"publisher","unstructured":"Xue, R., Li, X., Yang, L., Yang, M., Zhang, B., Zhang, X.,\u2026 Zhao, J. (2024). Evaluation and integration of cell-free DNA signatures for detection of lung cancer. Cancer Letters, 604, 217216. https:\/\/doi.org\/10.1016\/j.canlet.2024.217216","DOI":"10.1016\/j.canlet.2024.217216"},{"key":"10569_CR50","doi-asserted-by":"publisher","unstructured":"Planchard, D., Popat, S., Kerr, K., Novello, S., Smit, E. F., Faivre-Finn, C.,\u2026 Peters,S. (2018). Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 29, iv192\u2013iv237. https:\/\/doi.org\/10.1093\/annonc\/mdy275","DOI":"10.1093\/annonc\/mdy275"},{"key":"10569_CR51","doi-asserted-by":"publisher","unstructured":"Mooradian, M. J., Piotrowska, Z., Drapkin, B. J., Dias-Santagata, D., Marcoux, N.,Arnaoutakis, K.,\u2026 Sequist, L. V. (2017). Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer\u2013Transformed EGFR Mutant Non\u2013Small-Cell Lung Cancer. JCO precision oncology, 1, 10.1200\/PO.17.00123. https:\/\/doi.org\/10.1200\/PO.17.00123","DOI":"10.1200\/PO.17.00123"},{"key":"10569_CR52","doi-asserted-by":"publisher","unstructured":"Shirasawa, M., Yoshida, T., Shiraishi, K., Takigami, A., Takayanagi, D., Imabayashi,T.,\u2026 Ohe, Y. (2023). Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy. Lung Cancer, 179, 107183. https:\/\/doi.org\/10.1016\/j.lungcan.2023.107183","DOI":"10.1016\/j.lungcan.2023.107183"},{"key":"10569_CR53","doi-asserted-by":"publisher","unstructured":"Song, P., Wu, L. R., Yan, Y. H., Zhang, J. X., Chu, T., Kwong, L. N.,\u2026 Zhang, D.Y. (2022). Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics. Nature Biomedical Engineering, 6(3), 232\u2013245. https:\/\/doi.org\/10.1038\/s41551-021-00837-3","DOI":"10.1038\/s41551-021-00837-3"},{"key":"10569_CR54","doi-asserted-by":"publisher","unstructured":"Heeke, S., Gay, C. M., Estecio, M. R., Tran, H., Morris, B. B., Zhang, B.,\u2026 Heymach,J. V. (2024). Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes. Cancer cell, 42(2), 225. https:\/\/doi.org\/10.1016\/j.ccell.2024.01.001","DOI":"10.1016\/j.ccell.2024.01.001"},{"key":"10569_CR55","doi-asserted-by":"publisher","unstructured":"Hiatt, J. B., Doebley, A.-L., Arnold, H. U., Adil, M., Sandborg, H., Persse, T. W.,\u2026 MacPherson, D. (2024). Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions. Science Advances, 10(15), eadk2082. https:\/\/doi.org\/10.1126\/sciadv.adk2082","DOI":"10.1126\/sciadv.adk2082"},{"key":"10569_CR56","doi-asserted-by":"publisher","unstructured":"Liu, Y., Liu, Y.-S., Wu, P.-F., Li, Q., Dai, W.-M., Yuan, S.,\u2026 Li, B. (2015). Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis. The International Journal of Biochemistry & Cell Biology, 66, 11\u201319. https:\/\/doi.org\/10.1016\/j.biocel.2015.06.019","DOI":"10.1016\/j.biocel.2015.06.019"},{"issue":"6","key":"10569_CR57","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.3892\/ol.2017.7089","volume":"14","author":"S Mu","year":"2017","unstructured":"Mu S, Ma H, Shi J, Zhen D (2017) The expression of S100B protein in serum of patients with brain metastases from small-cell lung cancer and its clinical significance. Oncol Lett 14(6):7107\u20137110. https:\/\/doi.org\/10.3892\/ol.2017.7089","journal-title":"Oncol Lett"},{"key":"10569_CR58","doi-asserted-by":"publisher","first-page":"603271","DOI":"10.3389\/fonc.2021.603271","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Jing W, Jia W, Zhai X, Zhu H, Yu J (2021) Downregulation of LncRNA XR_429159.1 linked to brain metastasis in patients with Limited-Stage Small-Cell lung Cancer. Front Oncol 11:603271. https:\/\/doi.org\/10.3389\/fonc.2021.603271","journal-title":"Front Oncol"},{"key":"10569_CR59","doi-asserted-by":"publisher","unstructured":"Bando, H., Nakamura, Y., Taniguchi, H., Shiozawa, M., Yasui, H., Esaki, T.,\u2026 Yoshino,T. (2022). Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer. JCO Precision Oncology. https:\/\/doi.org\/10.1200\/PO.21.00535","DOI":"10.1200\/PO.21.00535"},{"key":"10569_CR60","doi-asserted-by":"publisher","unstructured":"Liu, M. C., MacKay, M., Kase, M., Piwowarczyk, A., Lo, C., Schaeffer, J.,\u2026 Park,B. H. (2022). Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer. JCO Precision Oncology. https:\/\/doi.org\/10.1200\/PO.21.00321","DOI":"10.1200\/PO.21.00321"},{"key":"10569_CR61","doi-asserted-by":"publisher","unstructured":"Tanjak, P., Chaiboonchoe, A., Suwatthanarak, T., Thanormjit, K., Acharayothin, O.,Chanthercrob, J.,\u2026 Chinswangwatanakul, V. (2024). Tumor-immune hybrid cells evade the immune response and potentiate colorectal cancer metastasis through CTLA4. Clinical and Experimental Medicine, 25(1), 2. https:\/\/doi.org\/10.1007\/s10238-024-01515-9","DOI":"10.1007\/s10238-024-01515-9"},{"key":"10569_CR62","doi-asserted-by":"publisher","first-page":"116947","DOI":"10.1016\/j.bios.2024.116947","volume":"270","author":"Y Dai","year":"2025","unstructured":"Dai Y, He J, Zhou Y, Yu Y, Hui H, Guo L, Yin H (2025) Constructing a highly sensitive duplex immunoassay using AuNPs and AgNPs as nanolabels for investigating the epithelial-mesenchymal transition occurring on Circulating tumor cells with lung cancer patients. Biosens Bioelectron 270:116947. https:\/\/doi.org\/10.1016\/j.bios.2024.116947","journal-title":"Biosens Bioelectron"},{"key":"10569_CR63","doi-asserted-by":"publisher","unstructured":"Shen, X., Dai, J., Guo, L., Liu, Z., Yang, L., Gu, D.,\u2026 Shi, Q. (2024). Single-cell low-pass whole genome sequencing accurately detects circulating tumor cells for liquid biopsy-based multi-cancer diagnosis. NPJ Precision Oncology, 8, 30. https:\/\/doi.org\/10.1038\/s41698-024-00520-1","DOI":"10.1038\/s41698-024-00520-1"},{"key":"10569_CR64","doi-asserted-by":"publisher","unstructured":"Ni, X., Zhuo, M., Su, Z., Duan, J., Gao, Y., Wang, Z.,\u2026 Wang, J. (2013). Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proceedings of the National Academy of Sciences, 110(52), 21083\u201321088. https:\/\/doi.org\/10.1073\/pnas.1320659110","DOI":"10.1073\/pnas.1320659110"},{"key":"10569_CR65","unstructured":"Jules Bordet Institute (2023) A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours - BrainStorm Program (Clinical trial registration No. NCT04109131). clinicaltrials.gov. Retrieved from https:\/\/clinicaltrials.gov\/study\/NCT04109131"},{"key":"10569_CR66","doi-asserted-by":"publisher","unstructured":"Kotecki, N., Martins-Branco, D., Nader-Marta, G., Gombos, A., Barthelemy, P., Gon\u00e7alves,A.,\u2026 Awada, A. (2024). Abstract CT202: CSFctDNA as a surrogate for tumor tissue DNA in BC pts with CNS metastases: First results from the Brainstorm program (Oncodistinct 006). Cancer Research, 84(7_Supplement), CT202. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-CT202","DOI":"10.1158\/1538-7445.AM2024-CT202"},{"key":"10569_CR67","doi-asserted-by":"publisher","first-page":"893490","DOI":"10.3389\/fcell.2022.893490","volume":"10","author":"M-Y Chen","year":"2022","unstructured":"Chen M-Y, Zeng Y-C, Zhao X-H (2022) Chemotherapy- and immune-Related gene panel in prognosis prediction and immune microenvironment of SCLC. Front Cell Dev Biology 10:893490. https:\/\/doi.org\/10.3389\/fcell.2022.893490","journal-title":"Front Cell Dev Biology"},{"key":"10569_CR68","doi-asserted-by":"publisher","unstructured":"Belluomini, L., Calvetti, L., Inno, A., Pasello, G., Roca, E., Vattemi, E.,\u2026 Pilotto,S. (2022). SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs.Frontiers in Oncology, 12, 840783. https:\/\/doi.org\/10.3389\/fonc.2022.840783","DOI":"10.3389\/fonc.2022.840783"},{"issue":"1","key":"10569_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00432-023-05544-x","volume":"150","author":"L Zhu","year":"2024","unstructured":"Zhu L, Qin J (2024) Predictive biomarkers for immunotherapy response in extensive-stage SCLC. J Cancer Res Clin Oncol 150(1):22. https:\/\/doi.org\/10.1007\/s00432-023-05544-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"10569_CR70","doi-asserted-by":"publisher","unstructured":"Schwendenwein, A., Megyesfalvi, Z., Barany, N., Valko, Z., Bugyik, E., Lang, C.,\u2026Dome, B. (2021). Molecular profiles of small cell lung cancer subtypes: therapeutic implications. Molecular Therapy Oncolytics, 20, 470. https:\/\/doi.org\/10.1016\/j.omto.2021.02.004","DOI":"10.1016\/j.omto.2021.02.004"},{"key":"10569_CR71","doi-asserted-by":"publisher","unstructured":"Qi J, Zhang J, Liu N, Zhao L, Xu B (2022) Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity. Frontiers in Oncology, 12. https:\/\/doi.org\/10.3389\/fonc.2022.779276","DOI":"10.3389\/fonc.2022.779276"},{"key":"10569_CR72","doi-asserted-by":"publisher","unstructured":"Zhang, Y., Yang, Z., Chen, R., Zhu, Y., Liu, L., Dong, J.,\u2026 Zhou, M. (2024). Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer. NPJ Digital Medicine, 7, 15. https:\/\/doi.org\/10.1038\/s41746-024-01003-0","DOI":"10.1038\/s41746-024-01003-0"},{"key":"10569_CR73","doi-asserted-by":"publisher","unstructured":"Ul Haq, S. U., Schmid, S., Aparnathi, M. K., Hueniken, K., Zhan, L. J., Sacdalan,D.,\u2026 Lok, B. H. (2022). Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. iScience, 25(12), 105487. https:\/\/doi.org\/10.1016\/j.isci.2022.105487","DOI":"10.1016\/j.isci.2022.105487"},{"key":"10569_CR74","doi-asserted-by":"publisher","unstructured":"Zhang, J., Zhou, N., Deng, H., Chen, X., Chen, Q., Wang, Q.,\u2026 Guo, L. (2023). Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer. Lung Cancer, 178, 11\u201319. https:\/\/doi.org\/10.1016\/j.lungcan.2023.01.015","DOI":"10.1016\/j.lungcan.2023.01.015"},{"key":"10569_CR75","doi-asserted-by":"publisher","unstructured":"Nong, J., Gong, Y., Guan, Y., Yi, X., Yi, Y., Chang, L.,\u2026 Wang, J. (2018). Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer. Nature Communications, 9(1), 3114. https:\/\/doi.org\/10.1038\/s41467-018-05327-w","DOI":"10.1038\/s41467-018-05327-w"},{"key":"10569_CR76","doi-asserted-by":"publisher","unstructured":"Iams, W. T., Kopparapu, P. R., Yan, Y., Muterspaugh, A., Zhao, Z., Chen, H.,\u2026 Lovly,C. M. (2020). Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease. JTO Clinical and Research Reports, 1(2), 100024. https:\/\/doi.org\/10.1016\/j.jtocrr.2020.100024","DOI":"10.1016\/j.jtocrr.2020.100024"},{"key":"10569_CR77","doi-asserted-by":"publisher","unstructured":"Feng, Y., Liu, Y., Yuan, M., Dong, G., Zhang, H., Zhang, T.,\u2026 Hu, X. (2021). The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer. Cancer Research and Treatment: Official Journal of Korean Cancer Association, 54(3), 753. https:\/\/doi.org\/10.4143\/crt.2021.905","DOI":"10.4143\/crt.2021.905"},{"key":"10569_CR78","doi-asserted-by":"publisher","unstructured":"Hou, J.-M., Krebs, M. G., Lancashire, L., Sloane, R., Backen, A., Swain, R. K.,\u2026Dive, C. (2012). Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer.Journal of Clinical Oncology, 30(5), 525\u2013532. https:\/\/doi.org\/10.1200\/JCO.2010.33.3716","DOI":"10.1200\/JCO.2010.33.3716"},{"key":"10569_CR79","doi-asserted-by":"publisher","unstructured":"Devarakonda, S., Sankararaman, S., Herzog, B. H., Gold, K. A., Waqar, S. N., Ward,J.,\u2026 Morgensztern, D. (2019). Circulating Tumor DNA Profiling in Small Cell Lung Cancer Identifies Potentially Targetable Alterations. Clinical cancer research: an official journal of the American Association for Cancer Research, 25(20), 6119. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0879","DOI":"10.1158\/1078-0432.CCR-19-0879"},{"key":"10569_CR80","doi-asserted-by":"publisher","unstructured":"Sivapalan, L., Iams, W. T., Belcaid, Z., Scott, S. C., Niknafs, N., Balan, A.,\u2026 Anagnostou,V. (2023). Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer. Clinical Cancer Research, 29(12), 2310\u20132323. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-2242","DOI":"10.1158\/1078-0432.CCR-22-2242"},{"key":"10569_CR81","doi-asserted-by":"publisher","unstructured":"Zhang, B., Stewart, C. A., Wang, Q., Cardnell, R. J., Rocha, P., Fujimoto, J.,\u2026 Gay,C. M. (2022). Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer. British Journal of Cancer, 127(3), 569\u2013576. https:\/\/doi.org\/10.1038\/s41416-022-01811-9","DOI":"10.1038\/s41416-022-01811-9"},{"key":"10569_CR82","doi-asserted-by":"publisher","unstructured":"Abdel Karim, N. F., Miao, J., Reckamp, K. L., Gay, C. M., Byers, L. A., Zhao, Y.,\u2026 Kelly, K. (2023). SWOG S1929: Phase II randomized study of maintenance atezolizumab(A) versus atezolizumab\u2009+\u2009talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC). Journal of Clinical Oncology, 41(16_suppl), 8504\u20138504. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.8504","DOI":"10.1200\/JCO.2023.41.16_suppl.8504"},{"key":"10569_CR83","doi-asserted-by":"publisher","unstructured":"Messaritakis, I., Nikolaou, M., Koinis, F., Politaki, E., Koutsopoulos, A., Lagoudaki,E.,\u2026 Kotsakis, A. (2019). Characterization of DLL3-positive circulating tumor cells(CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment. Lung Cancer, 135, 33\u201339. https:\/\/doi.org\/10.1016\/j.lungcan.2019.06.025","DOI":"10.1016\/j.lungcan.2019.06.025"},{"key":"10569_CR84","unstructured":"Amgen (2024) A Phase 3b, Multicenter, Single-arm, Expanded Access Protocol of Tarlatamab (AMG 757) for the Treatment of Subjects With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment (Clinical trial registration No. NCT06064500). clinicaltrials.gov. Retrieved from https:\/\/clinicaltrials.gov\/study\/NCT06064500"},{"key":"10569_CR85","unstructured":"Amgen (2024) A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy (Clinical trial registration No. NCT06117774). clinicaltrials.gov. Retrieved from https:\/\/clinicaltrials.gov\/study\/NCT06117774"},{"key":"10569_CR86","doi-asserted-by":"publisher","unstructured":"Gay, C. M., Allison Stewart, C., Park, E. M., Diao, L., Groves, S. M., Heeke, S.,\u2026 Byers, L. A. (2021). Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.Cancer cell, 39(3), 346\u2013360.e7. https:\/\/doi.org\/10.1016\/j.ccell.2020.12.014","DOI":"10.1016\/j.ccell.2020.12.014"},{"key":"10569_CR87","doi-asserted-by":"publisher","unstructured":"Lorenzi, M., Resi, M. V., Bonanno, L., Frega, S., Maso, A. D., Ferro, A.,\u2026 Pasello,G. (2024). Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients. Frontiers in Immunology, 15, 1308109. https:\/\/doi.org\/10.3389\/fimmu.2024.1308109","DOI":"10.3389\/fimmu.2024.1308109"},{"issue":"4","key":"10569_CR88","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/biom14040396","volume":"14","author":"R Fasano","year":"2024","unstructured":"Fasano R, Serrat\u00ec S, Rafaschieri T, Longo V, Fonte RD, Porcelli L, Azzariti A (2024) Small-Cell lung cancer: is liquid biopsy a new tool able to predict the efficacy of immunotherapy?? Biomolecules 14(4):396. https:\/\/doi.org\/10.3390\/biom14040396","journal-title":"Biomolecules"},{"issue":"4","key":"10569_CR89","doi-asserted-by":"publisher","first-page":"397","DOI":"10.21037\/tlcr.2017.08.01","volume":"6","author":"A Lallo","year":"2017","unstructured":"Lallo A, Schenk MW, Frese KK, Blackhall F, Dive C (2017) Circulating tumor cells and CDX models as a tool for preclinical drug development. Translational Lung Cancer Res 6(4):397\u2013408. https:\/\/doi.org\/10.21037\/tlcr.2017.08.01","journal-title":"Translational Lung Cancer Res"},{"issue":"8","key":"10569_CR90","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41419-023-06059-6","volume":"14","author":"Z Kahounov\u00e1","year":"2023","unstructured":"Kahounov\u00e1 Z, P\u00edckov\u00e1 M, Dr\u00e1pela S, Bouchal J, Szczyrbov\u00e1 E, Navr\u00e1til J, Sou\u010dek K (2023) Circulating tumor cell-derived preclinical models: current status and future perspectives. Cell Death Disease 14(8):530. https:\/\/doi.org\/10.1038\/s41419-023-06059-6","journal-title":"Cell Death Disease"},{"key":"10569_CR91","doi-asserted-by":"publisher","unstructured":"Pan C, Wang X, Yang C, Fu K, Wang F, Fu L (2024) The culture and application of Circulating tumor cell-derived organoids. Trends Cell Biol 0962892424002101. https:\/\/doi.org\/10.1016\/j.tcb.2024.10.004","DOI":"10.1016\/j.tcb.2024.10.004"},{"key":"10569_CR92","doi-asserted-by":"publisher","first-page":"104622","DOI":"10.1016\/j.critrevonc.2025.104622","volume":"207","author":"JA P\u00e9rez-Cabello","year":"2025","unstructured":"P\u00e9rez-Cabello JA, Artero-Castro A, Molina-Pinelo S (2025) Small cell lung cancer unveiled: exploring the untapped resource of Circulating tumor cells-derived organoids. Crit Rev Oncol\/Hematol 207:104622. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104622","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"10569_CR93","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12935-019-1067-8","volume":"19","author":"C Yang","year":"2019","unstructured":"Yang C, Xia B-R, Jin W-L, Lou G (2019) Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model. Cancer Cell Int 19(1):341. https:\/\/doi.org\/10.1186\/s12935-019-1067-8","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10569_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers11010019","volume":"11","author":"M Tellez-Gabriel","year":"2018","unstructured":"Tellez-Gabriel M, Cochonneau D, Cad\u00e9 M, Jubelin C, Heymann M-F, Heymann D (2018) Circulating tumor Cell-Derived Pre-Clinical models for personalized medicine. Cancers 11(1):19. https:\/\/doi.org\/10.3390\/cancers11010019","journal-title":"Cancers"},{"key":"10569_CR95","doi-asserted-by":"publisher","unstructured":"Huang, L., Xu, Y., Wang, N., Yi, K., Xi, X., Si, H.,\u2026 Wang, F. (2024). Next-Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC\u2010Derived Organoids.Small Methods, 8(1), 2301009. https:\/\/doi.org\/10.1002\/smtd.202301009","DOI":"10.1002\/smtd.202301009"},{"issue":"4","key":"10569_CR96","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.trecan.2023.01.004","volume":"9","author":"KN Suvilesh","year":"2023","unstructured":"Suvilesh KN, Manjunath Y, Pantel K, Kaifi JT (2023) Preclinical models to study patient-derived Circulating tumor cells and metastasis. Trends Cancer 9(4):355\u2013371. https:\/\/doi.org\/10.1016\/j.trecan.2023.01.004","journal-title":"Trends Cancer"},{"key":"10569_CR97","doi-asserted-by":"publisher","unstructured":"Li, W., Chen, Z., Lu, M., Lu, Z., Fu, S., Wu, Y.,\u2026 Wang, J. (2024). Neural network models based on clinical characteristics for predicting immunotherapy efficacy in small cell lung cancer. Malignancy Spectrum, 1(3), 162\u2013174. https:\/\/doi.org\/10.1002\/msp2.41","DOI":"10.1002\/msp2.41"},{"key":"10569_CR98","doi-asserted-by":"publisher","unstructured":"Zhao, J., He, Y., Yang, X., Tian, P., Zeng, L., Huang, K.,\u2026 Xia, Y. (2023). Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer:an integrated clinical and radiomics approach. Journal for Immunotherapy of Cancer, 11(9), e007492. https:\/\/doi.org\/10.1136\/jitc-2023-007492","DOI":"10.1136\/jitc-2023-007492"},{"key":"10569_CR99","doi-asserted-by":"publisher","unstructured":"Shibaki, R., Fujimoto, D., Nozawa, T., Sano, A., Kitamura, Y., Fukuoka, J.,\u2026 Akamatsu,H. (2024). Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer. Journal for Immunotherapy of Cancer, 12(2), e007987. https:\/\/doi.org\/10.1136\/jitc-2023-007987","DOI":"10.1136\/jitc-2023-007987"},{"issue":"3","key":"10569_CR100","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1093\/oncolo\/oyad261","volume":"29","author":"X Shang","year":"2024","unstructured":"Shang X, Zhang C, Kong R, Zhao C, Wang H (2024) Construction of a diagnostic model for small cell lung Cancer combining metabolomics and integrated machine learning. Oncologist 29(3):e392\u2013e401. https:\/\/doi.org\/10.1093\/oncolo\/oyad261","journal-title":"Oncologist"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10569-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:25:36Z","timestamp":1766852736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10569-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10569"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10569-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"455"}}